Annual Short Term Debt
$1.16 M
+$224.00 K+24.06%
31 December 2021
Summary:
Concert Pharmaceuticals annual short term debt is currently $1.16 million, with the most recent change of +$224.00 thousand (+24.06%) on 31 December 2021. During the last 3 years, it has risen by +$224.00 thousand (+24.06%).CNCE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$1.34 M
+$65.00 K+5.08%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly short term debt is currently $1.34 million, with the most recent change of +$65.00 thousand (+5.08%) on 30 September 2022.CNCE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +24.1% | +22.7% |
| 5 y5 years | +100.0% | +472.3% |
CNCE Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -85.8% | -84.2% |
Concert Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $1.34 M(+5.1%) |
| June 2022 | - | $1.28 M(+5.3%) |
| Mar 2022 | - | $1.22 M(+5.3%) |
| Dec 2021 | $1.16 M(+24.1%) | $1.16 M(+5.4%) |
| Sept 2021 | - | $1.10 M(+5.5%) |
| June 2021 | - | $1.04 M(+5.6%) |
| Mar 2021 | - | $984.00 K(+5.7%) |
| Dec 2020 | $931.00 K(+247.4%) | $931.00 K(+5.8%) |
| Sept 2020 | - | $880.00 K(+5.9%) |
| June 2020 | - | $831.00 K(+6.1%) |
| Mar 2020 | - | $783.00 K(+192.2%) |
| Dec 2019 | $268.00 K | $268.00 K(+14.0%) |
| Sept 2019 | - | $235.00 K(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $202.00 K(+19.5%) |
| Mar 2019 | - | $169.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2015 | - | $775.00 K(-73.5%) |
| June 2015 | - | $2.93 M(-41.9%) |
| Mar 2015 | - | $5.04 M(-29.1%) |
| Dec 2014 | $7.10 M(-12.9%) | $7.10 M(-14.9%) |
| Sept 2014 | - | $8.35 M(-1.8%) |
| June 2014 | - | $8.50 M(+2.1%) |
| Mar 2014 | - | $8.32 M(+2.1%) |
| Dec 2013 | $8.15 M(+58.4%) | $8.15 M(+2.1%) |
| Sept 2013 | - | $7.98 M(+55.2%) |
| Dec 2012 | $5.14 M(+1449.4%) | $5.14 M |
| Dec 2011 | $332.00 K | - |
FAQ
- What is Concert Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual short term debt?
The current annual short term debt of CNCE is $1.16 M
What is the all time high annual short term debt for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual short term debt is $8.15 M
What is Concert Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of CNCE is $1.34 M
What is the all time high quarterly short term debt for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly short term debt is $8.50 M